In the January 2019 issue (Volume 13, Number 1), in the article on pages 26‐28, “Locoregenional Therapy for Hepatocellular Carcinoma: Transarterial Chemoembolization Versus Transarterial Radioembolization Versus Stereotactic Body Radiotherapy,” by Laura Kulik, M.D., M.P.H., there is a spelling error in the title. The correct title should read, “Locoregional Therapy for Hepatocellular Carcinoma: Transarterial Chemoembolization Versus Transarterial Radioembolization Versus Stereotactic Body Radiotherapy.” The publisher regrets the error.
. 2019 Aug 2;14(1):42. doi: 10.1002/cld.820
Erratum
Collection date 2019 Jul.
© 2019 by the American Association for the Study of Liver Diseases
PMCID: PMC6677006 PMID: 31391938
This corrects the article "Locoregional Therapy for Hepatocellular Carcinoma: Transarterial Chemoembolization Versus Transarterial Radioembolization Versus Stereotactic Body Radiotherapy
" in volume 13 on page 26.